Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
ProKidney Corp - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
PROK
Nasdaq
8731
https://prokidney.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for ProKidney Corp
ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations
- Mar 25th, 2024 10:05 am
ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights
- Mar 21st, 2024 11:49 pm
ProKidney to Participate in Jefferies Biotech on the Bay Summit
- Feb 29th, 2024 9:05 pm
Chamath Palihapitiya Stocks: 12 Stocks Pumped in the Last 10 Years
- Dec 29th, 2023 1:22 pm
Here's Why ProKidney Corp. (PROK) Is a Great 'Buy the Bottom' Stock Now
- Dec 13th, 2023 2:55 pm
ProKidney Appoints Nikhil Pereira-Kamath, MBA, as Chief Business Officer
- Nov 30th, 2023 11:05 am
7 Penny Stocks With Low Floats and High Short Interest
- Nov 24th, 2023 11:40 am
ProKidney to Participate in a Fireside Chat at the Upcoming Evercore ISI 6th Annual HEALTHCONx Conference
- Nov 21st, 2023 11:05 am
ProKidney Corp. (NASDAQ:PROK) Q3 2023 Earnings Call Transcript
- Nov 17th, 2023 6:38 pm
Companies Like ProKidney (NASDAQ:PROK) Are In A Position To Invest In Growth
- Nov 17th, 2023 10:19 am
After Plunging -37.39% in 4 Weeks, Here's Why the Trend Might Reverse for ProKidney Corp. (PROK)
- Nov 16th, 2023 2:35 pm
ProKidney Corp (PROK) Reports Q3 Financial Results: Focus on Chronic Kidney Disease Trials
- Nov 14th, 2023 12:04 pm
ProKidney Reports Third Quarter Financial Results
- Nov 14th, 2023 11:05 am
ProKidney Announces Positive Interim Data from RMCL-002 Phase 2 Clinical Trial of Renal Autologous Cell Therapy (REACT®) for Diabetic CKD and Provides Corporate Updates
- Nov 13th, 2023 10:02 pm
ProKidney Announces Four Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2023
- Oct 30th, 2023 8:12 pm
ProKidney Corp. (PROK) Loses -54.93% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
- Oct 17th, 2023 1:35 pm
Why Shares of ProKidney Were Dropping Thursday
- Oct 12th, 2023 7:05 pm
ProKidney to Participate in Fireside Chat at the Morgan Stanley Global Healthcare Conference
- Sep 5th, 2023 10:05 am
3 Biotech Stocks Due for a Massive Short Squeeze
- Aug 31st, 2023 2:33 pm
ProKidney Reports Second Quarter Financial Results and Recent Corporate Highlights
- Aug 10th, 2023 8:10 pm
Scroll